Hassan Raza: A Smarter Risk Prediction in MPNs Using AI
Hassan Raza, Consultant Hematologist and Transfusion Medicine Specialist, shared on LinkedIn about a recent article by Xuezi Hu et al, published in Blood, adding:
”AI Enhancing Risk Prediction in MPNs
A recent American Society of Hematology (Blood 2025) study introduces MEAM – an AI model analyzing bone marrow morphology in ET and PV.
What it does:
Predicts multiple outcomes:
• Thrombosis/bleeding
• Myelofibrosis progression
• AML transformation
• Overall survival
Why it stands out:
Matches or exceeds traditional models (IPSET, R-IPSET-T)
Improves prediction when combined with clinical scores
Detects high-risk patients missed by conventional tools, especially younger patients
Clinical relevance:
Moves morphology from subjective assessment to a quantifiable, dynamic prognostic tool
Takeaway:
AI-integrated morphology may significantly refine risk stratification and treatment decisions in MPNs.”
Title: Multi-endpoint AI morphology model (MEAM) enhances risk prediction for vascular events and disease progression in MPNs
Authors: Xuezi Hu, Alan Aberdeen, Sharon Ruane, Rosalin Cooper, Timothy Ebsworth, Sanam Loghavi, David Ross, Diana Iarossi, Markus Tiemann, Amin Turki, Andrew Sung, Mingyi Chen, Zijun Xu-Monette, Ken Young, Anna Godfrey, Jyoti Nangalia, Joanna Baxter, Anthony Green, Mary Frances McMullin, Adam Mead, Claire Harrison, Jens Rittscher, Korsuk Sirinukunwattana, Daniel Royston
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 16:54Ralf Ludwig։ Testing Human-Targeted Therapies in a Human Immune System
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia
-
Sep 3, 2026, 15:42Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology
-
Sep 3, 2026, 15:37Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 15:18Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis
-
Sep 3, 2026, 15:10Tvisha Subhasish: Extravascular Factor IX Beyond the Circulation